Table 3.
Positively Selected Sites | No. of Negatively Selected Sites | Mean dN/dS | |||||
---|---|---|---|---|---|---|---|
SLAC a | FEL a | FUBA b | SLAC a | FEL a | FUBAR b | ||
CPV-2 VP2 gene | Non | Non | 426 | 8 | 46 | 31 | 0.108 |
a p value of <0.05. b Posterior probability of ≥0.95.
Positively Selected Sites | No. of Negatively Selected Sites | Mean dN/dS | |||||
---|---|---|---|---|---|---|---|
SLAC a | FEL a | FUBA b | SLAC a | FEL a | FUBAR b | ||
CPV-2 VP2 gene | Non | Non | 426 | 8 | 46 | 31 | 0.108 |
a p value of <0.05. b Posterior probability of ≥0.95.